PARTNERS OF JSI medical systems

JSI medical systems closely interacts with many important companies in the field of genetics, mainly sequencing platform manufacturers and enrichment/capture kit producers.


Protrans offers kits for HLA sequence based typing. All Protrans sequencing systems are designed to to be analyzed with the SEQUENCE Pilot modules SEQHLA or SEQNEXT-HLA.

SEQHLA is recommended for the data analysis of Sanger sequencing data. Predefined AmpModules and SeqPrimers for Protrans HLA SBT analysis can be easily imported in the SEQHLA installation by importing the ProtransKits file.

SEQNEXT-HLA is recommended as NGS Allele Identification software for Protrans HLA NGS Sequencing (Protrans N5).

Devyser offers diagnostic kits for complex DNA testing within oncology, reproductive health and hereditary diseases. Their products are used to guide targeted cancer therapies, to enable rapid prenatal diagnostics, as well as in a wide array of genetic tests. JSI developed a customized software plug-in that is compatible with all Devyser products, including BRCA, CFTR, Thalassemia, FH kits for NGS.

Pre-defined files are available for import in SEQNEXT. These contain all settings, such as regions of interest and validated analysis settings for mutation analysis including CNV detection.

Ulf Klangby, CEO and co-founder of Devyser, says, “Being able to offer our NGS kits to users of JSI’s software platform is a fantastic opportunity for us. JSI’s reputation of being at the forefront of bio-informatic platform development is completely aligned with our own philosophy of meeting the needs of the routine diagnostic lab, in this case those with full analytic capacity in-house.”

Joachim Strub, CEO of JSI medical systems, comments, “We are excited to enable a robust NGS solution together with Devyser. This will empower our customers and future users of the JSI platform to maintain full control of their analytical processes and results using the latest NGS technology.”

Download press release from November 2016.

NimaGen offers EasySeq NGS Targeted Capture kits for BRCA1/BRCA2 and for Hereditary Breast and Ovararian Cancer (HBOC). Using sequence capturing with single molecule Molecular Inversion Probes (smMIP), followed by a barcoding Amplification step, the system enables sequencing of the targeted regions in a very simple, fast and robust workflow, resulting in coverage with double probe tiling and independent reading of both strands.

SEQNEXT is recommended for the analysis of EasySeq NGS Targeted Capture Kits.
Download brochure

By collaborating with experts from Interactive Biosoftware, we have been able to develop a link between SEQNEXT, SEQPATIENT and Alamut Visual.

SEQNEXT, SEQPATIENT and Alamut Visual are now automatically connected: any variant found by SEQNEXT, SEQPATIENT can be directly visualized and interpreted within Alamut Visual.